NCT02701023: Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma |
|
|
| No Longer Available | N/A | | US | MitoGel | Jonsson Comprehensive Cancer Center, UroGen Pharma Ltd. | Urothelial Carcinoma Ureteral Location | | | | |
uTRACT, NCT05874921: Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto |
|
|
| Recruiting | N/A | 400 | US | Jelmyto (mitomycin) for pyelocalyceal solution, Jelmyto, UGN-101 | UroGen Pharma Ltd. | Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter, Urothelial Carcinoma Ureter Recurrent, Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis | 04/25 | 01/28 | | |
